Work

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.18_suppl.cra501

Authors: A. Tutt, M. Robson, J. E. Garber, S. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, J. Carmichael

Institutions: Guy's Hospital, Memorial Sloan Kettering Cancer Center, King's College London, Dana-Farber Cancer Institute, University of Pennsylvania

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4242011915

Cites:

Cited by: 120

Related to: 10